Combination phenylbutyrate/gemcitabine therapy effectively inhibits in vitro and in vivo growth of NSCLC by intrinsic apoptotic pathways. JOC. 2007;6(1). Accessed February 5, 2026. https://carcinogenesis.com/index.php/JOC/article/view/205